Binhui Bio has a clinically transformative VAK (virus activated killer) cell therapy and Bat-T (BsAb activated) cell therapy platform and can provide the whole process design of preclinical and clinical research for T cell, NK cell, DC cell, and other cell therapies, including preclinical pharmacodynamics, safety evaluation, production SOPs, quality inspection SOPs, design, and development of clinical research protocols, etc. It can also provide consultation and design services for pilot-scale clean rooms that meet GMP standards.